Mei Wu

3.0k total citations · 1 hit paper
51 papers, 2.3k citations indexed

About

Mei Wu is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mei Wu has authored 51 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 16 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mei Wu's work include Kawasaki Disease and Coronary Complications (17 papers), Coronary Artery Anomalies (11 papers) and Bone health and treatments (7 papers). Mei Wu is often cited by papers focused on Kawasaki Disease and Coronary Complications (17 papers), Coronary Artery Anomalies (11 papers) and Bone health and treatments (7 papers). Mei Wu collaborates with scholars based in China, United States and United Kingdom. Mei Wu's co-authors include Gary Meininger, B Charbonnel, Avraham Karasik, Ji Liu, Russell Scott, Peter Stein, Peter P. Stein, Arthur C. Santora, Philip D. Ross and Richard D. Wasnich and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Annals of the Rheumatic Diseases.

In The Last Decade

Mei Wu

46 papers receiving 2.1k citations

Hit Papers

Efficacy and Safety of th... 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Wu China 18 1.3k 826 791 765 488 51 2.3k
Cristian Guja Romania 20 1.2k 1.0× 630 0.8× 88 0.1× 637 0.8× 30 0.1× 86 2.2k
Hui Huang China 19 457 0.4× 274 0.3× 221 0.3× 284 0.4× 64 0.1× 99 1.2k
Benedetta Maria Bonora Italy 23 1.2k 0.9× 592 0.7× 215 0.3× 503 0.7× 8 0.0× 52 2.0k
Itzhak Rosner Israel 23 321 0.3× 152 0.2× 99 0.1× 259 0.3× 50 0.1× 74 1.9k
Rosalinda Posadas‐Sánchez Mexico 22 355 0.3× 308 0.4× 166 0.2× 300 0.4× 26 0.1× 136 1.7k
C.J. Haines Hong Kong 20 357 0.3× 305 0.4× 247 0.3× 77 0.1× 88 0.2× 45 1.4k
David A. Sass United States 16 139 0.1× 150 0.2× 208 0.3× 354 0.5× 82 0.2× 52 1.1k
Rafael Velázquez‐Cruz Mexico 24 119 0.1× 652 0.8× 166 0.2× 90 0.1× 130 0.3× 101 1.6k
George Chan Canada 18 94 0.1× 479 0.6× 192 0.2× 151 0.2× 108 0.2× 30 1.1k

Countries citing papers authored by Mei Wu

Since Specialization
Citations

This map shows the geographic impact of Mei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Wu more than expected).

Fields of papers citing papers by Mei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Wu. The network helps show where Mei Wu may publish in the future.

Co-authorship network of co-authors of Mei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Wu. A scholar is included among the top collaborators of Mei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Wu. Mei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yanfu, et al.. (2024). Prognostic evaluation of a multi-target magnetic bead-enriched circulating tumor cell-enriched identification system for colorectal cancer. Journal of Gastrointestinal Oncology. 15(1). 134–146. 1 indexed citations
3.
Luo, Yigang, Mei Wu, & Hongguang Chen. (2024). Retrospective analysis of pathological types and imaging features in pancreatic cancer: A comprehensive study. World Journal of Gastrointestinal Oncology. 17(1). 99153–99153.
4.
Wu, Mei, Shuran Shao, Kaiyu Zhou, et al.. (2023). Development of a nomogram prediction model for early identification of persistent coronary artery aneurysms in kawasaki disease. BMC Pediatrics. 23(1). 79–79. 6 indexed citations
5.
Lu, Zhihua, Kaijian Xia, Heng Jiang, Xiaoyan Weng, & Mei Wu. (2023). Improved effects of the b-value for 2000 sec/mm2 DWI on an accurate qualitative and quantitative assessment of rectal cancer. Arab Journal of Gastroenterology. 24(4). 230–237.
6.
Lu, Zhihua, Kaijian Xia, Heng Jiang, Jianlong Jiang, & Mei Wu. (2021). Textural differences based on apparent diffusion coefficient maps for discriminating pT3 subclasses of rectal adenocarcinoma. World Journal of Clinical Cases. 9(24). 6987–6998. 2 indexed citations
7.
Shao, Shuran, Lixia Yang, Xiaoliang Liu, et al.. (2021). Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: A prospective cohort study. Pediatric Allergy and Immunology. 32(6). 1349–1359. 9 indexed citations
9.
Qiao, Lina, Yimin Hua, Shuran Shao, et al.. (2021). Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study. Pediatric Rheumatology. 19(1). 147–147. 4 indexed citations
10.
Liu, Xiaoliang, Kaiyu Zhou, Yimin Hua, et al.. (2020). Grisel’s syndrome in Kawasaki disease. Orphanet Journal of Rare Diseases. 15(1). 246–246. 5 indexed citations
11.
Liu, Xiaoliang, Kaiyu Zhou, Yimin Hua, et al.. (2020). Neurological involvement in Kawasaki disease: a retrospective study. Pediatric Rheumatology. 18(1). 61–61. 27 indexed citations
12.
Shao, Shuran, Chunyan Luo, Kaiyu Zhou, et al.. (2019). Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study. Pediatric Rheumatology. 17(1). 78–78. 12 indexed citations
13.
Raz, Itamar, Yu Chen, Mei Wu, et al.. (2008). Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes. Current Medical Research and Opinion. 24(2). 537–550. 227 indexed citations
14.
Hooper, Michael, Augusto Faustino, Ian R. Reid, et al.. (2008). Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget’s disease. Osteoporosis International. 20(1). 141–150. 6 indexed citations
15.
Hanefeld, M, et al.. (2007). Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes. Current Medical Research and Opinion. 23(6). 1329–1339. 139 indexed citations
16.
Wu, Mei, Hui Li, Kaiyuan Wu, et al.. (2006). Regulating effects of novel CpG chitosan-nanoparticles on immune responses of mice to porcine paratyphoid vaccines.. PubMed. 19(4). 315–22. 7 indexed citations
17.
Yang, Yi, Hui Li, Yingyi Wang, et al.. (2006). Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comparative Immunology Microbiology and Infectious Diseases. 30(1). 19–32. 32 indexed citations
18.
Scott, Russell, et al.. (2006). Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes. International Journal of Clinical Practice. 61(1). 171–180. 218 indexed citations
19.
Dobs, Adrian S., Helmut G. Schrott, Michael H. Davidson, et al.. (2000). Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism. 49(9). 1234–1238. 82 indexed citations
20.
Tonino, Richard P., Pierre J. Meunier, Ronald Emkey, et al.. (2000). Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1. The Journal of Clinical Endocrinology & Metabolism. 85(9). 3109–3115. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026